Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease

Andreas Schüller, Zheng Yin*, C. S. Brian Chia, Danny N.P. Doan, Hyeong Kyu Kim, Luqing Shang, Teck Peng Loh, Jeffery Hill, Subhash G. Vasudevan

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

89 Citations (Scopus)

Abstract

A series of tripeptide aldehyde inhibitors were synthesized and their inhibitory effect against dengue virus type 2 (DENV2) and West Nile virus (WNV) NS3 protease was evaluated side by side with the aim to discover potent flaviviral protease inhibitors and to examine differences in specificity of the two proteases. The synthesized inhibitors feature a varied N-terminal cap group and side chain modifications of a P 2-lysine residue. In general a much stronger inhibitory effect of the tripeptide inhibitors was observed toward WNV protease. The inhibitory concentrations against DENV2 protease were in the micromolar range while they were submicromolar against WNV. The data suggest that a P 2-arginine shifts the specificity toward DENV2 protease while WNV protease favors a lysine in the P 2 position. Peptides with an extended P 2-lysine failed to inhibit DENV2 protease suggesting a size-constrained S 2 pocket. Our results generally encourage the investigation of di- and tripeptide aldehydes as inhibitors of DENV and WNV protease.

Original languageEnglish
Pages (from-to)96-101
Number of pages6
JournalAntiviral Research
Volume92
Issue number1
DOIs
Publication statusPublished - Oct 2011
Externally publishedYes

ASJC Scopus Subject Areas

  • Pharmacology
  • Virology

Keywords

  • Dengue virus
  • NS2B-NS3 protease
  • Peptide inhibitor
  • West nile virus

Fingerprint

Dive into the research topics of 'Tripeptide inhibitors of dengue and West Nile virus NS2B-NS3 protease'. Together they form a unique fingerprint.

Cite this